BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giri J, Das R, Nylen E, Chinnadurai R, Galipeau J. CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury. Cell Rep 2020;30:1923-1934.e4. [PMID: 32049021 DOI: 10.1016/j.celrep.2020.01.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Lipat AJ, Cottle C, Pirlot BM, Mitchell J, Pando B, Helmly B, Kosko J, Rajan D, Hematti P, Chinnadurai R. Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. Stem Cells Transl Med 2022:szac050. [PMID: 35881077 DOI: 10.1093/stcltm/szac050] [Reference Citation Analysis]
2 Bikorimana J, Saad W, Abusarah J, Lahrichi M, Talbot S, Shammaa R, Rafei M. CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties. Cells 2022;11:2263. [DOI: 10.3390/cells11152263] [Reference Citation Analysis]
3 Galipeau J, Krampera M, Leblanc K, Nolta JA, Phinney DG, Shi Y, Tarte K, Viswanathan S, Martin I. Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy 2021;23:368-72. [PMID: 33714704 DOI: 10.1016/j.jcyt.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Molnar V, Pavelić E, Vrdoljak K, Čemerin M, Klarić E, Matišić V, Bjelica R, Brlek P, Kovačić I, Tremolada C, Primorac D. Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. Genes 2022;13:949. [DOI: 10.3390/genes13060949] [Reference Citation Analysis]
5 Camba-Gómez M, Gualillo O, Conde-Aranda J. New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation. Int J Mol Sci 2021;22:2605. [PMID: 33807591 DOI: 10.3390/ijms22052605] [Reference Citation Analysis]
6 Farge D, Loisel S, Resche-rigon M, Lansiaux P, Colmegna I, Langlais D, Charles C, Pugnet G, Maria ATJ, Chatelus E, Martin T, Hachulla E, Kheav VD, Lambert NC, Wang H, Michonneau D, Martinaud C, Sensebé L, Cras A, Tarte K. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study. The Lancet Rheumatology 2022;4:e91-e104. [DOI: 10.1016/s2665-9913(21)00326-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Leonard NA, Reidy E, Thompson K, McDermott E, Peerani E, Tomas Bort E, Balkwill FR, Loessner D, Ryan AE. Stromal Cells Promote Matrix Deposition, Remodelling and an Immunosuppressive Tumour Microenvironment in a 3D Model of Colon Cancer. Cancers (Basel) 2021;13:5998. [PMID: 34885111 DOI: 10.3390/cancers13235998] [Reference Citation Analysis]
8 Stadler M, Pudelko K, Biermeier A, Walterskirchen N, Gaigneaux A, Weindorfer C, Harrer N, Klett H, Hengstschläger M, Schüler J, Sommergruber W, Oehler R, Bergmann M, Letellier E, Dolznig H. Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages. Cancer Lett 2021;520:184-200. [PMID: 34256095 DOI: 10.1016/j.canlet.2021.07.006] [Reference Citation Analysis]
9 He F, Umrath F, von Ohle C, Reinert S, Alexander D. Analysis of the Influence of Jaw Periosteal Cells on Macrophages Phenotype Using an Innovative Horizontal Coculture System. Biomedicines 2021;9:1753. [PMID: 34944569 DOI: 10.3390/biomedicines9121753] [Reference Citation Analysis]
10 Fields L, Ito T, Kobayashi K, Ichihara Y, Podaru MN, Hussain M, Yamashita K, Machado V, Lewis-McDougall F, Suzuki K. Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data. Mol Ther 2021;29:2554-70. [PMID: 33887461 DOI: 10.1016/j.ymthe.2021.04.018] [Reference Citation Analysis]
11 Giri J, Galipeau J. Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. Blood Adv 2020;4:1987-97. [PMID: 32384543 DOI: 10.1182/bloodadvances.2020001711] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
12 Wang Y, Qi Z, Yan Z, Ji N, Yang X, Gao D, Hu L, Lv H, Zhang J, Li M. Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease. Front Cell Dev Biol 2021;9:742088. [PMID: 35096808 DOI: 10.3389/fcell.2021.742088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Srinivasan A, Sathiyanathan P, Yin L, Liu TM, Lam A, Ravikumar M, Smith RAA, Loh HP, Zhang Y, Ling L, Ng SK, Yang YS, Lezhava A, Hui J, Oh S, Cool SM. Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sethakorn N, Heninger E, Sánchez-de-Diego C, Ding AB, Yada RC, Kerr SC, Kosoff D, Beebe DJ, Lang JM. Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment. Cancers (Basel) 2022;14:757. [PMID: 35159026 DOI: 10.3390/cancers14030757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Dunn CM, Kameishi S, Grainger DW, Okano T. Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies. Acta Biomater 2021;133:114-25. [PMID: 33857693 DOI: 10.1016/j.actbio.2021.03.069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
16 Bikorimana JP, El-Hachem N, El-Kadiry AE, Abusarah J, Salame N, Shammaa R, Rafei M. Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells. Front Immunol 2020;11:596303. [PMID: 33542714 DOI: 10.3389/fimmu.2020.596303] [Reference Citation Analysis]
17 Farge D, Loisel S, Lansiaux P, Tarte K. Mesenchymal stromal cells for systemic sclerosis treatment. Autoimmun Rev 2021;20:102755. [PMID: 33476823 DOI: 10.1016/j.autrev.2021.102755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Barkama R, Mayo A, Paz A, Solopov A, Mann T, Vadasz Z, Appel T, Ofir R, Shani L, Sheleg M, Allen H, Shaked Nitzan R, Tsarfaty N, Gilad H, Birch T, Kachel E, Reinke P, Volk HD, Zalts R, Raz Pasteur A. Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019. Crit Care Explor 2020;2:e0207. [PMID: 32984833 DOI: 10.1097/CCE.0000000000000207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Crippa S, Santi L, Berti M, De Ponti G, Bernardo ME. Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome. Front Cell Dev Biol 2021;9:663316. [PMID: 34017834 DOI: 10.3389/fcell.2021.663316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Kanazawa S, Okada H, Hojo H, Ohba S, Iwata J, Komura M, Hikita A, Hoshi K. Mesenchymal stromal cells in the bone marrow niche consist of multi-populations with distinct transcriptional and epigenetic properties. Sci Rep 2021;11:15811. [PMID: 34349154 DOI: 10.1038/s41598-021-94186-5] [Reference Citation Analysis]
21 Figliuolo da Paz VR, Jamwal DR, Kiela PR. Intestinal Regulatory T Cells. Adv Exp Med Biol 2021;1278:141-90. [PMID: 33523448 DOI: 10.1007/978-981-15-6407-9_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chiaranunt P, Tai SL, Ngai L, Mortha A. Beyond Immunity: Underappreciated Functions of Intestinal Macrophages. Front Immunol 2021;12:749708. [PMID: 34650568 DOI: 10.3389/fimmu.2021.749708] [Reference Citation Analysis]
23 Cascio S, Chandler C, Zhang L, Sinno S, Gao B, Onkar S, Bruno TC, Vignali DAA, Mahdi H, Osmanbeyoglu HU, Vlad AM, Coffman LG, Buckanovich RJ. Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition. Sci Adv 2021;7:eabi5790. [PMID: 34767446 DOI: 10.1126/sciadv.abi5790] [Reference Citation Analysis]
24 Mahmoudi M, Hoseinzadeh A, Rezaieyazdi Z, Afshari JT, Mahmoudi A, Heydari S. Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocytes Concerning Lupus Disease. Stem Cell Rev and Rep. [DOI: 10.1007/s12015-022-10397-x] [Reference Citation Analysis]
25 Pagella P, de Vargas Roditi L, Stadlinger B, Moor AE, Mitsiadis TA. A single-cell atlas of human teeth. iScience 2021;24:102405. [PMID: 33997688 DOI: 10.1016/j.isci.2021.102405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Lu D, Xu Y, Liu Q, Zhang Q. Mesenchymal Stem Cell-Macrophage Crosstalk and Maintenance of Inflammatory Microenvironment Homeostasis. Front Cell Dev Biol 2021;9:681171. [PMID: 34249933 DOI: 10.3389/fcell.2021.681171] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Barros I, Silva A, de Almeida LP, Miranda CO. Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy. Cytokine Growth Factor Rev 2021;58:114-33. [PMID: 33397585 DOI: 10.1016/j.cytogfr.2020.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Vázquez A, Fernández-Sevilla LM, Jiménez E, Pérez-Cabrera D, Yañez R, Subiza JL, Varas A, Valencia J, Vicente A. Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy. Front Immunol 2020;11:567391. [PMID: 33329530 DOI: 10.3389/fimmu.2020.567391] [Reference Citation Analysis]
29 Camba-Gómez M, Arosa L, Gualillo O, Conde-Aranda J. Chemokines and chemokine receptors in inflammatory bowel disease: Recent findings and future perspectives. Drug Discov Today 2021:S1359-6446(21)00538-9. [PMID: 34896626 DOI: 10.1016/j.drudis.2021.12.004] [Reference Citation Analysis]
30 Dunbar H, Weiss DJ, Rolandsson Enes S, Laffey JG, English K. The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing. Cells 2021;10:2982. [PMID: 34831203 DOI: 10.3390/cells10112982] [Reference Citation Analysis]
31 Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Front Immunol. 2020;11:1091. [PMID: 32574263 DOI: 10.3389/fimmu.2020.01091] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 23.5] [Reference Citation Analysis]
32 Wang T, Suita Y, Miriyala S, Dean J, Tapinos N, Shen J. Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy. Pharmaceutics 2021;13:520. [PMID: 33918635 DOI: 10.3390/pharmaceutics13040520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Boland L, Bitterlich LM, Hogan AE, Ankrum JA, English K. Translating MSC Therapy in the Age of Obesity. Front Immunol 2022;13:943333. [DOI: 10.3389/fimmu.2022.943333] [Reference Citation Analysis]
34 Tan L, Liu X, Dou H, Hou Y. Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment — specific factors involved in the regulation of MSC plasticity. Genes & Diseases 2022;9:296-309. [DOI: 10.1016/j.gendis.2020.10.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wang L, Hu Y, Song B, Xiong Y, Wang J, Chen D. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease. Inflamm Res 2021;70:753-64. [PMID: 34212215 DOI: 10.1007/s00011-021-01482-x] [Reference Citation Analysis]
36 Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, Hua D, Shao C, Shi Y. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-00932-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Gonzalez-pujana A, Beloqui A, Javier Aguirre J, Igartua M, Santos-vizcaino E, Maria Hernandez R. Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.01.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Planat-Benard V, Varin A, Casteilla L. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism. Front Immunol 2021;12:626755. [PMID: 33995350 DOI: 10.3389/fimmu.2021.626755] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tamouza R, Volt F, Richard J, Wu C, Bouassida J, Boukouaci W, Lansiaux P, Cappelli B, Scigliuolo GM, Rafii H, Kenzey C, Mezouad E, Naamoune S, Chami L, Lejuste F, Farge D, Gluckman E. Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review. Front Cell Dev Biol 2022;10:809686. [DOI: 10.3389/fcell.2022.809686] [Reference Citation Analysis]
40 Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell 2021;28:1708-25. [PMID: 34624232 DOI: 10.1016/j.stem.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol 2021;97:107823. [PMID: 34102486 DOI: 10.1016/j.intimp.2021.107823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Carty F, Dunbar H, Hawthorne IJ, Ting AE, Stubblefield SR, Van't Hof W, English K. IFN-γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease. Stem Cells Transl Med 2021. [PMID: 34397170 DOI: 10.1002/sctm.21-0008] [Reference Citation Analysis]
43 Semenova E, Grudniak MP, Machaj EK, Bocian K, Chroscinska-Krawczyk M, Trochonowicz M, Stepaniec IM, Murzyn M, Zagorska KE, Boruczkowski D, Kolanowski TJ, Oldak T, Rozwadowska N. Mesenchymal Stromal Cells from Different Parts of Umbilical Cord: Approach to Comparison & Characteristics. Stem Cell Rev Rep 2021. [PMID: 33860454 DOI: 10.1007/s12015-021-10157-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Fischer M, Schoon J, Freund E, Miebach L, Weltmann KD, Bekeschus S, Wassilew GI. Biocompatible Gas Plasma Treatment Affects Secretion Profiles but Not Osteogenic Differentiation in Patient-Derived Mesenchymal Stromal Cells. Int J Mol Sci 2022;23:2038. [PMID: 35216160 DOI: 10.3390/ijms23042038] [Reference Citation Analysis]
45 Lopez-Santalla M, Garin MI. Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases. Biomedicines 2021;9:1507. [PMID: 34829736 DOI: 10.3390/biomedicines9111507] [Reference Citation Analysis]
46 Giri J, Moll G. MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel. Curr Stem Cell Rep. [DOI: 10.1007/s40778-022-00207-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Gallo A, Cuscino N, Contino F, Bulati M, Pampalone M, Amico G, Zito G, Carcione C, Centi C, Bertani A, Conaldi PG, Miceli V. Changes in the Transcriptome Profiles of Human Amnion-Derived Mesenchymal Stromal/Stem Cells Induced by Three-Dimensional Culture: A Potential Priming Strategy to Improve Their Properties. Int J Mol Sci 2022;23:863. [PMID: 35055049 DOI: 10.3390/ijms23020863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Hochheuser C, Kunze NY, Tytgat GAM, Voermans C, Timmerman I. The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery. J Pers Med 2021;11:161. [PMID: 33668854 DOI: 10.3390/jpm11030161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Shan Q, Takabatake K, Omori H, Kawai H, Oo MW, Nakano K, Ibaragi S, Sasaki A, Nagatsuka H. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma. Int J Oncol 2021;59:72. [PMID: 34368860 DOI: 10.3892/ijo.2021.5252] [Reference Citation Analysis]
50 Wagoner ZW, Zhao W. Therapeutic implications of transplanted-cell death. Nat Biomed Eng 2021;5:379-84. [PMID: 34002064 DOI: 10.1038/s41551-021-00729-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]